Mesoblast Limited - stock earnings
MESO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -21.9 million USD | 2.1 million USD |
| 2023Q1 | -18.6 million USD | 1.9 million USD |
| 2022Q4 | -24.5 million USD | 2.0 million USD |
| 2022Q3 | -16.9 million USD | 1.4 million USD |
| 2022Q2 | -16.9 million USD | 1.4 million USD |
| 2022Q1 | -21.3 million USD | 2.0 million USD |
| 2021Q4 | -25.9 million USD | 2.4 million USD |
| 2021Q3 | -22.6 million USD | 3.6 million USD |
| 2021Q2 | -22.1 million USD | 2.0 million USD |
| 2021Q1 | -26.5 million USD | 1.9 million USD |
| 2020Q4 | -25.7 million USD | 2.2 million USD |
| 2020Q3 | -24.5 million USD | 1.3 million USD |
| 2020Q2 | -32.6 million USD | 692000 USD |
| 2020Q1 | -15.3 million USD | 12.1 million USD |
| 2019Q4 | -24.6 million USD | 2.0 million USD |
| 2019Q3 | -5.5 million USD | 16.9 million USD |
| 2019Q2 | -20.7 million USD | 2.0 million USD |
| 2019Q1 | -25.0 million USD | 1.2 million USD |
| 2018Q4 | -24.6 million USD | 1.9 million USD |
| 2018Q3 | -19.5 million USD | 11.6 million USD |
| 2018Q2 | -20.8 million USD | 1.7 million USD |
| 2018Q1 | -21.1 million USD | 991000 USD |
| 2017Q4 | 13.7 million USD | 13.3 million USD |
| 2017Q3 | -7.0 million USD | 1.2 million USD |
| 2017Q2 | -27.2 million USD | 566000 USD |
| 2017Q1 | -9.8 million USD | 901000 USD |
| 2016Q4 | -20.1 million USD | 550000 USD |
| 2016Q3 | -19.8 million USD | 395000 USD |
| 2016Q2 | 48.3 million USD | 26.9 million USD |
| 2016Q1 | -16.9 million USD | 4.1 million USD |
| 2015Q4 | -22.3 million USD | 4.0 million USD |
| 2015Q3 | -13.2 million USD | 7.5 million USD |
| 2015Q2 | -53.7 million USD | 8.2 million USD |
| 2015Q1 | -22.2 million USD | 4.2 million USD |
| 2014Q4 | -27.9 million USD | 4.4 million USD |
| 2014Q3 | -15.5 million USD | 7.0 million USD |
| 2014Q2 | -23.2 million USD | 2.4 million USD |
| 2014Q1 | -23.5 million USD | 2.6 million USD |
| 2013Q4 | -16.4 million USD | 6.3 million USD |
| 2013Q3 | -11.7 million USD | 11.9 million USD |
| 2013Q2 | -15.5 million USD | 9.1 million USD |
| 2013Q1 | -17.6 million USD | 10.4 million USD |
| 2012Q4 | -14.4 million USD | 7.6 million USD |
| 2012Q3 | -14.4 million USD | 7.6 million USD |
MESO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -81.9 million USD | 7.5 million USD |
| 2022 | -91.3 million USD | 10.2 million USD |
| 2021 | -98.8 million USD | 7.5 million USD |
| 2020 | -77.9 million USD | 32.2 million USD |
| 2019 | -89.8 million USD | 16.7 million USD |
| 2018 | -35.3 million USD | 17.3 million USD |
| 2017 | -76.8 million USD | 2.4 million USD |
| 2016 | -4.1 million USD | 42.5 million USD |
| 2015 | -119.4 million USD | 23.7 million USD |
| 2014 | -81.0 million USD | 26.0 million USD |
| 2013 | -61.7 million USD | 28.8 million USD |
| 2012 | -71.1 million USD | 38.3 million USD |
| 2011 | 90.6 million USD | 120.9 million USD |
| 2010 | -14.8 million USD | 5500 USD |
| 2009 | -12.3 million USD | 890708 USD |
| 2008 | -10.1 million USD | 909807 USD |
| 2007 | -8.7 million USD | 1.7 million USD |
| 2006 | -8.3 million USD | 2.8 million USD |
| 2005 | -1.5 million USD | 502885 USD |
MESO
Price: $7.50
52 week price:
Earnings Per Share: -0.87 USD
P/E Ratio: -2.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 45251
Ebitda: -19.5 millionMarket Capitalization: 493.8 million